H
Loading...
Loading...
CDC PLACES does not publish a city-level diabetes row for Lexington. Use the national 12% (CDC National Diabetes Statistics Report) plus your own panel — do not invent a local rate. Census population 322,570. Kentucky Medicare wound biologics: CGS Administrators (J15). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Lexington clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Lexington storefront.
Sports Injury Biologic Treatments in Lexington, KY for clinics & physicians. Biologic treatments for sport… Compliance support & pricing — contact Hawk Medical.
CDC PLACES does not publish an arthritis rate for Lexington. Plan joint volume from your referral mix, not a made-up city figure. CDC PLACES does not publish a city-level diabetes row for Lexington. Use the national 12% (CDC National Diabetes Statistics Report) plus your own panel — do not invent a local rate. Together those PLACES numbers are why a city of 250k–500k still needs separate PRP and CTP protocols. sports injury biologics inventory is national; utilization is J15-local.
National Sports Injury Biologic Treatments notes (how the product actually works)J15 reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in Lexington is unpublished at place grain or not. PLACES is planning data. The LCD is the claim.
We are not going to invent a Lexington warehouse or a five-star local review. What you get is sports injury biologics from FDA-registered sources, lot paperwork, and someone who has run the same SOPs in clinic — Joe Bradley. The local numbers on this page are CDC PLACES and CMS J15, not marketing adjectives.
CDC PLACES has no incorporated-place row we could match for Lexington. We will not interpolate one from the state BRFSS range. Use the national 12% (CDC) plus your panel.
Kentucky includes Diabetes Belt counties in CDC’s published geography. That supports a higher index of suspicion for DFU and chronic-wound volume. It is not a license to skip offloading, vascular assessment, or J15 documentation.
The 96.5% figure is a product-level clinical experience statistic published on our wound-care materials — not a city-specific trial. Your outcomes will depend on patient selection, offloading, and follow-up.
No. PRP (autologous) and cellular/tissue products (allograft/skin substitutes) sit on different coding and coverage paths. CGS Administrators LCDs for CTPs do not automatically cover PRP injections. Build separate protocols and fee tickets.
If you operate in Kentucky and another MAC state, say it on the first call. J15 will not port 1:1. We would rather split utilization than watch a sister clinic copy Lexington tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Lexington, KY.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Lexington is J15 geography and published epidemiology — not a street address.
No PLACES city row. National CDC 12% is the floor until you use your own panel.
Kentucky Part B wound biologics follow this contractor (siblings: OH). We train to the articles. We do not write coverage.
City-proper population is scale for a city of 250k–500k, not a count of orthopedic groups.
No Lexington storefront. Joe Bradley is an active practice owner. sports injury biologics stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.